MedTrace Logo

Detection of Asymptomatic Atrial Fibrillation in Persons of 65 Year of Age or Older

NCT04375241 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2168

Last updated 2022-07-12

No results posted yet for this study

Summary

Atrial fibrillation (AF) is the most common cardiac arrhythmia. Although the condition itself is not life-threatening, the complications result in increased morbidity and mortality. AF is often asymptomatic and a considerable number of people suffering from AF are not aware of their condition. Unfortunately, a cerebral infarction is often the first clinical manifestation. The idea to screen subjects opportunistically for Asymptomatic Atrial Fibrillation (AAF) was infeasible until recently. However, with a recently-developed smartphone connected Mobile ECG Device (MED), this seems to be feasible after all.

The main objectives are:

* To examine the feasibility of screening subjects of ≥65 years old for AAF.
* To validate the smartphone connected MED as an AAF screening instrument for application in transmural care in the Netherlands.

Conditions

Interventions

OTHER

Subjects with asymptomatic atrial fibrillation will be screened by using a Mobile ECG Device

Subjects with asymptomatic atrial fibrillation will be screened by using a Mobile ECG Device

Sponsors & Collaborators

  • Diagram B.V.

    lead OTHER

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-07-02
Primary Completion
2021-04-30
Completion
2021-04-30

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04375241 on ClinicalTrials.gov